Bank of America’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-5,400
Closed -$143K 8342
2014
Q1
$143K Buy
+5,400
New +$135K ﹤0.01% 5698

Bank of America's IPXL Position: Q2 2018 in Review

Bank of America sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 227,221 shares — an estimated $4.42M sold.

Bank of America first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $4.42M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Bank of America reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bank of America sold 227,221 Impax Laboratories, Inc. shares in Q2 2018, an estimated $4.42M.
  • Bank of America first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
  • Bank of America's Impax Laboratories, Inc. position peaked at $4.42M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.